査読有
doi：10.1007/s00535-023-01985-w
種類：原著
誌名：Journal of Gastroenterology
発行年月：2023年3月
2021 Impact Factor：6.772
巻号頁：in press
論題：Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
著者：Reika Yamauchi, Takanori Ito, Sachiyo Yoshio, Takafumi Yamamoto, Kazuyuki Mizuno, Masatoshi Ishigami, Hiroki Kawashima, Satoshi Yasuda, Shigeo Shimose, Hideki Iwamoto, Taiji Yamazoe, Taizo Mori, Eiji Kakazu, Takumi Kawaguchi, Hidenori Toyoda, Tatsuya Kan